MIT's Technology Review checks in with Regulus, a startup owned by both Alnylam and Isis that focuses on developing miRNA-based drugs.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.
Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.
Vox explores a proposal to institute a lottery system to award grant funds.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.